Filter Search


Healthcare and Medical


Location Summary Deadline
Germany The Dak-gesundheit Is Initiating A Non-exclusive Discount Agreement Under § 130a Abs. 8 Sgb V For The Active Ingredient Colesevelam, Atc C10ac04, For The Period From 01.10.2025 To 30.09.2027, With An Option For A 12-month Extension. The Procedure Is Expec 2026-02-16
Germany The Techniker Krankenkasse Aims To Enter Into Discount Contracts With All Suitable Pharmaceutical Companies According To § 130a Abs. 8 Sgb V For The Active Ingredients, Combinations Of Active Ingredients, Or Forms Of Presentation, Strengths, Or Finished M 2026-02-16
Germany The Health Insurance Companies Aim To Conclude Discount Contracts With All Suitable Pharmaceutical Companies According To § 130a Abs. 8 Sgb V For The Active Ingredients, Active Ingredient Combinations, Or Dosage Forms, Strengths, Or Finished Medicinal Pro 2026-02-16
Germany The Health Insurance Companies Aim To Conclude Discount Contracts With All Suitable Pharmaceutical Companies According To § 130a Abs. 8 Sgb V For The Active Ingredients, Active Ingredient Combinations, Or Dosage Forms, Strengths, Or Finished Medicinal Pro 2026-02-16
Norway Electro Therapeutic Treatment Aids For The Health Authorities In Norway 2026-02-16
United Kingdom Supply Of Agency Workers For Care & Support Schemes 2026-02-16
United Kingdom Expressions Of Interest For The Provision Of Community Dental Services Across The West Midlands 2026-02-16
Germany Openhouser Discount Contracts 202510 2026-02-17
Germany Completion Of A Non-exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Elrombopag (patent-free Indication), Atc B02bx05 F.d.z. 01.10.25-30.09.27 (plus Extension Option 1x12 Month) 2026-02-17
Germany The Dak-gesundheit Is Initiating A Non-exclusive Discount Agreement For The Active Ingredient Dimethylfumarat (exclusively 240 Mg In Standard Size N3), Atc L04ax07, Effective From 01.10.2025 To 30.09.2027, With An Option For A 12-month Extension. The Proc 2026-02-17
Whats app